RETRACTED: El-Far et al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. <i>Biomedicines</i> 2021, <i>9</i>, 990
Ali H. El-Far,
Kavitha Godugu,
Taher A. Salaheldin,
Noureldien H. E. Darwish,
Amna A. Saddiq,
Shaker A. Mousa
Affiliations
Ali H. El-Far
Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
Kavitha Godugu
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
Taher A. Salaheldin
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
Noureldien H. E. Darwish
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
Amna A. Saddiq
Department of Biology, College of Sciences, University of Jeddah, Jeddah 21589, Saudi Arabia
Shaker A. Mousa
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
The journal retracts the article, “Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer” [...]
